BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6388815)

  • 1. Bone marrow transplantation in leukemia. Current status.
    Santos GW
    Cancer; 1984 Dec; 54(11 Suppl):2732-40. PubMed ID: 6388815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation in hematologic malignancies. Current status.
    Santos GW
    Cancer; 1990 Feb; 65(3 Suppl):786-91. PubMed ID: 2406002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC; McGuire TR
    Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation: current results in leukemia.
    Santos GW
    Yale J Biol Med; 1982; 55(5-6):477-85. PubMed ID: 6763816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone marrow transplantation after intensive chemotherapy].
    Masaoka T
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1650-5. PubMed ID: 3296959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation for acute leukemia: recent advances and comparison with alternative therapies.
    Champlin R; Gale RP
    Semin Hematol; 1987 Jan; 24(1):55-67. PubMed ID: 3547673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with interstitial pneumonia following allogeneic bone marrow transplantation for acute leukemia in Japanese experience.
    Inoue T; Masaoka T; Shibata H
    Strahlenther Onkol; 1986 Jun; 162(6):368-73. PubMed ID: 3526600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation for treatment of leukemia in children.
    Trigg ME
    Pediatr Clin North Am; 1988 Aug; 35(4):933-48. PubMed ID: 3047659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
    Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
    Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
    Kersey JH; Weisdorf D; Nesbit ME; LeBien TW; Woods WG; McGlave PB; Kim T; Vallera DA; Goldman AI; Bostrom B
    N Engl J Med; 1987 Aug; 317(8):461-7. PubMed ID: 3302708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of bone marrow transplantation in leukaemia and aplastic anaemia.
    Storb R; Santos GW
    Clin Haematol; 1983 Oct; 12(3):721-37. PubMed ID: 6357579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow transplantation in hematologic malignancies.
    Thomas ED
    Hosp Pract (Off Ed); 1987 Feb; 22(2):77-91. PubMed ID: 3027113
    [No Abstract]   [Full Text] [Related]  

  • 13. Allogeneic bone marrow transplantation.
    Weiden PL
    Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acute leukemia in adults with chemoradiotherapy and bone marrow transplantation.
    Appelbaum FR; Thomas ED
    Cancer; 1985 May; 55(9 Suppl):2202-9. PubMed ID: 3884138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of bone marrow transplantation to the treatment of children with leukemia].
    Vossen JM; van Leeuwen EF; van 't Veer-Korthof ET; Slaper-Cortenbach CM; van den Berg H; Gerritsen EJ; Hermans J; Weening RS
    Tijdschr Kindergeneeskd; 1988 Apr; 56(2):73-82. PubMed ID: 3287686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors].
    Nachbaur D; Schwaighofer H; Thaler J; Weyrer W; Fink M; Nussbaumer W; Fritsch E; Niederwieser D
    Wien Klin Wochenschr; 1994; 106(7):201-7. PubMed ID: 8197754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications, technique and risks in bone marrow transplantation in adulthood].
    Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
    Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants.
    Champlin RE; Gale RP
    Cancer Treat Rep; 1984 Jan; 68(1):145-61. PubMed ID: 6362862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.